Hantavirus in Tenerife
A clinical perspective on the MV Hondius outbreak — and on why measured assessment matters more than headlines.
Three people are dead. Six confirmed cases. A cruise ship anchored off the Canary Islands while nearly 150 passengers, most of them well, are extracted under a public health protocol the Spanish health minister has described as unprecedented. The Director-General of the World Health Organization is on the island in person. Police are guarding the dock. Local protests. An exhausted captain. A virus that almost no one was expecting to be the news this week.
The MV Hondius situation has, in the space of a fortnight, become the kind of event that triggers something specific in those of us who lived through 2020: a quick, almost reflexive scan for whether this is the next one. It almost certainly isn't. But the question deserves a serious answer rather than a dismissive one.
What we know, as of 10 May 2026, is that an outbreak of Andes virus — one of more than fifty hantaviruses, and the only one with documented human-to-human transmission — emerged on a Dutch-flagged cruise ship that left Ushuaia, Argentina, on 1 April. The first death came on 11 April. By the time the WHO was formally notified on 2 May, three passengers had died and a small cluster of severe respiratory illness had been identified on board. The ship, denied entry to several closer ports, has now arrived at the industrial port of Granadilla in Tenerife, with passengers being moved through a sealed corridor onto charter flights bound for their home countries. The WHO's assessment of the risk to the public is, in its words, low. CNN + 2
For most readers, this is the first time hantavirus has crossed the threshold of attention. A short primer is useful. Hantaviruses are a family of viruses carried, asymptomatically, by certain rodents. Humans usually become infected by inhaling tiny particles from rodent urine, droppings, or saliva — typically when cleaning enclosed spaces where rodents have been living, or in agricultural and rural settings. In the Americas, hantavirus infection often produces what is called hantavirus cardiopulmonary syndrome: a severe respiratory illness with a case fatality rate that can reach 50%. Andes virus specifically sits at around 30 to 40%. New England Journal of Medicine + 3
Those numbers are alarming and they should be read carefully. They describe what happens to the small number of people who become infected and reach hospital — they do not describe what happens to a population. Hantavirus infection is rare. Andes virus is rarer still outside South America. And while Andes is the one strain known to transmit between people, the published evidence suggests this happens almost exclusively in conditions of close, sustained contact — often family members, often during nursing care.
This is where the comparison with COVID-19 needs to be handled with some precision.
The early days of COVID had a similar texture: a respiratory virus, an outbreak on a cruise ship, an evacuation, a low-confidence assessment of risk. The reflex to read the Hondius story through that template is understandable. But the parallel is largely surface. SARS-CoV-2 was a respiratory virus that spread efficiently between people who barely knew each other, often without symptoms. Andes hantavirus does not behave that way. Person-to-person transmission, while documented, has been limited and traceable. There is no indication, currently, that any Hondius passenger is asymptomatically seeding wider community transmission. The Tenerife protocol — sealed vehicles, cordoned corridor, direct repatriation, no public contact — would not have worked for COVID. It can work, and is working, here. Wikipedia
What the Hondius situation does share with COVID is something less obvious. It is what we tend to call, in the clinical literature, a spillover event: a virus moving from its animal reservoir into people. The likely route in this case, according to the WHO, was bird-watching activity in regions where the long-tailed pygmy rice rat is endemic. Wherever and whenever humans and certain animals share habitat closely, spillover happens. It always has. What has changed is the rate at which it appears to happen, and the speed at which it can travel — a 69-year-old woman who became infected on a hiking trip in Patagonia is, less than a fortnight later, a confirmed case in Switzerland. That movement profile is genuinely new. NBC News
For our patients in the UK, the immediate clinical relevance is small. The risk to anyone living in Britain, or holidaying in Tenerife, or planning a trip to South America, remains low. Hand hygiene, careful avoidance of enclosed spaces with visible rodent activity, and standard travel precautions are sufficient. There is no public health justification, at this point, for any of us to change behaviour.
What the situation does deserve is attention. Not panic — attention. Hantavirus has been part of the global infectious disease picture for thirty years. In some ways, it is behaving exactly as it has always behaved. In other ways — the sustained spread on a cruise ship, the speed of dispersal across continents — the world it is moving through has changed. We will return to those changes in subsequent pieces. For now, the most useful posture is the one the WHO has modelled this week: measured, transparent, and unhurried.
